These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 36069935)

  • 1. Consensus statement on smoking cessation in patients with pain.
    Iida H; Yamaguchi S; Goyagi T; Sugiyama Y; Taniguchi C; Matsubara T; Yamada N; Yonekura H; Iida M
    J Anesth; 2022 Dec; 36(6):671-687. PubMed ID: 36069935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The smoking gun: many conditions associated with tobacco exposure may be attributable to paradoxical compensatory autonomic responses to nicotine.
    Yun AJ; Bazar KA; Lee PY; Gerber A; Daniel SM
    Med Hypotheses; 2005; 64(6):1073-9. PubMed ID: 15823687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between tobacco smoking and pain: A narrative review of the scientific literature].
    Balayssac D
    Rev Mal Respir; 2021 Mar; 38(3):269-277. PubMed ID: 33648775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Smoking on the Development and Severity of Chronic Pain.
    Robinson CL; Kim RS; Li M; Ruan QZ; Surapaneni S; Jones M; Pak DJ; Southerland W
    Curr Pain Headache Rep; 2022 Aug; 26(8):575-581. PubMed ID: 35731364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies.
    Simmons SJ; Gould TJ
    J Clin Pharm Ther; 2014 Oct; 39(5):457-67. PubMed ID: 24828779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Pain Status, Nicotine Withdrawal, and Expectancies for Smoking Cessation Among Lighter Smokers.
    Ditre JW; Kosiba JD; Zale EL; Zvolensky MJ; Maisto SA
    Ann Behav Med; 2016 Jun; 50(3):427-35. PubMed ID: 26813264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and pain: pathophysiology and clinical implications.
    Shi Y; Weingarten TN; Mantilla CB; Hooten WM; Warner DO
    Anesthesiology; 2010 Oct; 113(4):977-92. PubMed ID: 20864835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking Cessation in Chronic Obstructive Pulmonary Disease.
    Tashkin DP
    Semin Respir Crit Care Med; 2015 Aug; 36(4):491-507. PubMed ID: 26238637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women.
    Baraona LK; Lovelace D; Daniels JL; McDaniel L
    J Midwifery Womens Health; 2017 May; 62(3):253-269. PubMed ID: 28556464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain characteristics and nicotine deprivation as predictors of performance during a laboratory paradigm of smoking cessation.
    Powers JM; LaRowe LR; Heckman BW; Ditre JW
    Psychol Addict Behav; 2020 Mar; 34(2):341-350. PubMed ID: 31750703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking and Chronic Pain.
    Lankhorst MA
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):326-327. PubMed ID: 27797644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Society for Research on Nicotine and Tobacco.
    Heishman SJ; Balfour DJ; Benowitz NL; Hatsukami DK; Lindstrom JM; Ockene JK
    Addiction; 1997 May; 92(5):615-33. PubMed ID: 9219386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double target concept for smoking cessation.
    Wu J
    Acta Pharmacol Sin; 2010 Sep; 31(9):1015-8. PubMed ID: 20711220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiology of nicotine addiction: implications for smoking cessation treatment.
    Benowitz NL
    Am J Med; 2008 Apr; 121(4 Suppl 1):S3-10. PubMed ID: 18342164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.
    Moerke MJ; McMahon LR; Wilkerson JL
    Pharmacol Rev; 2020 Apr; 72(2):527-557. PubMed ID: 32205338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments.
    D'Souza MS; Markou A
    Addict Sci Clin Pract; 2011 Jul; 6(1):4-16. PubMed ID: 22003417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
    Smith LC; George O
    Neuropharmacology; 2020 Nov; 178():108225. PubMed ID: 32758566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to Tobacco, Environmental Tobacco Smoke and Nicotine in Pregnancy: A Pragmatic Overview of Reviews of Maternal and Child Outcomes, Effectiveness of Interventions and Barriers and Facilitators to Quitting.
    Gould GS; Havard A; Lim LL; The Psanz Smoking In Pregnancy Expert Group ; Kumar R
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32204415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.